CVS launches unit to market and co-produce biosimilars

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

(Reuters) - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and ...

STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and co-produce biosimilars for the U.S. market.

The company will also launch biosimilar Hyrimoz with Novartis' Sandoz from next year at a list price that is more than 80% lower to AbbVie's blockbuster arthritis drug Humira.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 45. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Global stock market correction likely before year-end: Reuters pollBy Hari Kishan BENGALURU (Reuters) - Global stock markets are heading for a correction in coming months, though overall they should post marginal gains ...
Källa: SaltWire Network - 🏆 45. / 63 Läs mer »